Aclaris Therapeutics Eulerpool Nyheder

Aclaris Therapeutics Aktie Nyheder

Aclaris Therapeutics bliver overvåget af mange journalister og investorer over hele verden. De seneste Aclaris Therapeutics nyheder samler vi her.

• 26. juni ·

  Yahoo
  Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
• 23. juni ·

  Yahoo
  Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
• 2. juni ·

  Yahoo
  Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
• 10. maj ·

  Yahoo
  Aclaris Therapeutics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
• 29. april ·

  Yahoo
  Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer
• 25. april ·

  Yahoo
  Strong week for Aclaris Therapeutics (NASDAQ:ACRS) shareholders doesn't alleviate pain of three-year loss
• 22. april ·

  Yahoo
  Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
• 4. marts ·

  Yahoo
  Aclaris Therapeutics to Participate in Two March Healthcare Conferences
• 4. marts ·

  Yahoo
  Aclaris Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
• 27. februar ·

  Yahoo
  Aclaris: Q4 Earnings Snapshot